Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein

Additional COVID-19 vaccines that are safe and immunogenic are needed for global vaccine equity. Here, we developed a recombinant type 5 adenovirus vector encoding for the SARS-CoV-2 S1 subunit antigen and nucleocapsid as a fusion protein (Ad5.SARS-CoV-2-S1N). A single subcutaneous immunization with...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad S, Kim, Eun, McPherson, Alex, Weisel, Florian J, Huang, Shaohua, Kenniston, Thomas W, Percivalle, Elena, Cassaniti, Irene, Baldanti, Fausto, Meisel, Marlies, Gambotto, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372896/
https://www.ncbi.nlm.nih.gov/pubmed/35967905
http://dx.doi.org/10.1093/abt/tbac015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372896/
https://www.ncbi.nlm.nih.gov/pubmed/35967905
http://dx.doi.org/10.1093/abt/tbac015

Ejemplares similares